H.R. 6130 · 119th Congress · Health
ASAP Act
No summary available to determine bill content. AI-read
- IntroducedNov 19, 2025 Done
- CommitteeReferred to 2 committees Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill provides for Medicare coverage of blood tests to screen for the early stages of Alzheimer’s disease or related dementias. Specifically, the bill provides for coverage of genomic sequencing blood or blood product tests, or other equivalent tests, that are approved by the Food and Drug Administration.
Congressional Research Service · summary of “Introduced in House” version · Nov 19, 2025
Who lobbies on it
6 organizations, more than 94% of House bills · 19 filings · Q4 2025–Q3 2026These 6 organizations’ PACs gave $790K to 95 of the 241 members sponsoring or cosponsoring H.R. 6130 in the 2025–26 election cycle.
One square per quarter since introduction, oldest left. Filled = named it that quarter.
-
Alzheimer's Association
4 of 4 quarters
“General issues related to detection, diagnosis and treatment of Alzheimer's and all other dementia; including the Alzheimer's Screening and Prevention Act of 2025 (H.R. 6130/S. 3267)”
$3.7M lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
Eisai Inc.
4 of 4 quarters
“General issues related to Medicare and Medicaid, including: Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order; Part D Program; enter for Medicare and Medicaid Innovation (CMMI) Drug Pricing Demonstration Programs; drug pricing, PBM reform; H.R. 6130 / S. 3267, the Alzheimers…”
$1.7M lobbying spend in 2026 to date, all issuesQ3 2026 filing
-
Biogen
3 of 4 quarters
“…H.R.6130/S.3267, ASAP Act, to provide coverage for blood based biomarker Alzheimer's disease diagnosis H.R.3747, AADAPT Act, to provide for training for primary care for screening, detection and diagnosis for Alzheimer's disease H.R.1262, Mikaela Naylon Give Kids a Chance Act, reauthorization of FDA Pediatric-Priority…”
$3.4M lobbying spend in 2026 to date, all issuesQ3 2026 filing
3 more organizations, every filingPROUpgrade
Organizations that named H.R. 6130 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
4 actions · newest first- Sep 16, 2026Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 40 - 0.
- Sep 16, 2026Committee Consideration and Mark-up Session Held
- Nov 19, 2025Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Nov 19, 2025Introduced in House
What members said about it
-
Bilirakis-Backed CHANGE Act to Improve Early Alzheimer’s Detection Advances Out of Committee
Congressman Gus Bilirakis (FL-12) applauded the House Ways and Means Committee’s unanimous advancement of bipartisan legislation containing provisions of the Concentrating on High-Value Alzheimer’s Needs to Get to an End (CHANGE) Act, which…
“Alzheimer’s is a devastating disease that has touched my family personally, so I understand the tremendous toll it takes not only on patients, but also on the loved ones who care for them.”
-
Expanding access to early detection will give millions of Americans the opportunity to plan ahead and seek preventative care.
“Early detection of Alzheimer’s is key to giving families more time, options and hope.”
-
Buchanan Named Most Bipartisan Member in Florida in National Congressional Scorecard
Earns an “A” Grade in Bridge Grades Nonpartisan Congressional Scorecard WASHINGTON — Congressman Vern Buchanan has earned an “A” grade with a score of 96.9 out of 100 from Bridge Grades, a nonpartisan scorecard that rates members of…
“Floridians didn’t send me to Washington to fight for the sake of fighting.”
-
ICYMI: Alzheimer’s Association Highlights Urgent Need for ASAP Act on Fox News
Advocates Call for Passage of ASAP Act with nearly 200 Bipartisan Cosponsors WASHINGTON — Today, Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chairman of the Health Subcommittee, highlights the growing…
-
Advocates Passage of Alzheimer’s Screening and Prevention (ASAP) Act to Support Early Detection of Alzheimer’s and Dementia WASHINGTON — Today, Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chairman of…
“As someone who cared for a parent with this horrible disease, I believe that it is critical for Congress to recognize the impact that Alzheimer’s and dementia have on the millions of Americans diagnosed every year, as well as the caregivers who support them.”
-
Working Towards Improved Care for Our Man’amko
Former Saipan resident LJ Duenas (second from left) led the Alzheimer’s Association Aloha Chapter in meetings across Capitol Hill to advocate for individuals living with Alzheimer’s disease and other forms of dementia.
-
ICYMI: Buchanan, Tonko Push for Alzheimer’s Screening and Prevention in Punchbowl News Interview
Advocate to Pass ASAP Act with 100+ Bipartisan Cosponsors WASHINGTON — Yesterday, Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chairman of the Health Subcommittee, joined Congressman Paul Tonko (D-N.Y.)…
“I want to kick it off on the conversation of the day here with talking about the Alzheimer’s Screening and Prevention Act, otherwise known as the ASAP Act. Congressman Buchanan, this is something you are spearheading. This is a bill that aims to have Medicare cover these newly developed blood tests for early detection…”
-
Saving Role of Early Detection and Prevention in Reducing Cancer’s Long-Term Impact WASHINGTON — Congressman Vern Buchanan, Vice Chairman of the House Ways and Means Committee and Chairman of the Health Subcommittee, recently joined…
“Cancer touches nearly every family in America, and too many lives are lost because it isn’t caught early.”
-
Ciscomani Hosts HHS Secretary Kennedy and HRSA Admin Engels, Holds Roundtable with Local Leadership
Congressman Juan Ciscomani this week hosted Secretary Robert F. Kennedy Jr. of the U.S. Department of Health and Human Services and Administrator Thomas Engels of the Health Resources and Services Administration on a visit to Arizona’s…
“It was an honor to join Secretary Kennedy at this roundtable and bring together local leaders alongside a fearless advocate who has championed our shared goal of making America healthy again.”
-
Leading Alzheimer’s Advocates Urge Support for Buchanan’s ASAP Act
459 Organizations and Researchers Call on Congress to Fight Alzheimer’s: “The Need for Action is Urgent.”
“Early detection of Alzheimer’s disease is key to giving families more time, options and hope.”